Parkin' control: regulation of PGC-1α through PARIS in Parkinson's disease
Saved in:
Main Author: | Jorge Iván Castillo-Quan (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2011-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From white to brown fat through the PGC-1α-dependent myokine irisin: implications for diabetes and obesity
by: Jorge Iván Castillo-Quan
Published: (2012) -
Prospects for the Development of Pink1 and Parkin Activators for the Treatment of Parkinson's Disease
by: Alexander V. Blagov, et al.
Published: (2022) -
Chiisanoside Mediates the Parkin/ZNF746/PGC-1α Axis by Downregulating MiR-181a to Improve Mitochondrial Biogenesis in 6-OHDA-Caused Neurotoxicity Models In Vitro and In Vivo: Suggestions for Prevention of Parkinson's Disease
by: Yu-Ling Hsu, et al.
Published: (2023) -
Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson's disease in rats
by: Sanaa Ahmed, et al.
Published: (2022) -
α-Arbutin ameliorates UVA-induced photoaging through regulation of the SIRT3/PGC-1α pathway
by: Fang Lu, et al.
Published: (2024)